Renal toxicity of methotrexate
- PMID: 5763245
- DOI: 10.1002/1097-0142(196901)23:1<126::aid-cncr2820230115>3.0.co;2-#
Renal toxicity of methotrexate
Similar articles
-
Methotrexate therapy for squamous cell carcinomas of the head and neck. Intermittent intravenous dose program.JAMA. 1968 May 13;204(7):561-4. JAMA. 1968. PMID: 5694477 No abstract available.
-
Measurement of renal function without urine collection. A critical evaluation of the constant-infusion technic for determination of inulin and para-aminohippurate.N Engl J Med. 1972 Nov 30;287(22):1109-14. doi: 10.1056/NEJM197211302872202. N Engl J Med. 1972. PMID: 5082190 No abstract available.
-
Methotrexate (NSC-740) in squamous cell carcinoma of the head and neck. II. Intermittent intravenous therapy.Cancer Chemother Rep. 1967 Apr;51(2):69-72. Cancer Chemother Rep. 1967. PMID: 6043731 No abstract available.
-
The effect of organic acids on renal clearance of methotrexate in man.Clin Pharmacol Ther. 1969 Nov-Dec;10(6):849-57. doi: 10.1002/cpt1969106849. Clin Pharmacol Ther. 1969. PMID: 5349626 No abstract available.
-
Mit gelber Zunge und rotem Urin.MMW Fortschr Med. 2021 Nov;163(19):30. doi: 10.1007/s15006-021-0490-7. MMW Fortschr Med. 2021. PMID: 34708366 Review. German. No abstract available.
Cited by
-
Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy.Cancer Chemother Pharmacol. 1981;6(1):59-64. doi: 10.1007/BF00253011. Cancer Chemother Pharmacol. 1981. PMID: 7273267
-
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy.Cancer Chemother Pharmacol. 2024 Jul;94(1):89-101. doi: 10.1007/s00280-024-04664-6. Epub 2024 Mar 13. Cancer Chemother Pharmacol. 2024. PMID: 38478074 Free PMC article. Clinical Trial.
-
Lack of drug interaction between levetiracetam and high-dose methotrexate in patients with lymphoma.Pharmacotherapy. 2021 May;41(5):430-439. doi: 10.1002/phar.2516. Epub 2021 Mar 16. Pharmacotherapy. 2021. PMID: 33655525 Free PMC article.
-
The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80.Cancer Chemother Pharmacol. 1985;14(3):238-42. doi: 10.1007/BF00258124. Cancer Chemother Pharmacol. 1985. PMID: 3995684
-
Ocular absorption and toxicity of methotrexate in the dog.Can Vet J. 1985 Sep;26(9):263-6. Can Vet J. 1985. PMID: 17422568 Free PMC article.